← Back to Stock / ETF implied volatility screener# KNSA - Kiniksa Pharmaceuticals - Class A

Implied Volatility Analysis

**Implied Volatility:**

233.7%

Implied Volatility Analysis

233.7%

**Kiniksa Pharmaceuticals - Class A** has an **Implied Volatility (IV)** of **233.7%** p.a. for a constant maturity of 30 days. The **Implied Volatility Rank (IVR)** for KNSA is **31** and the **Implied Volatility Percentile (IVP)** is **77**. The current Implied Volatility Index for KNSA is 0.51 standard deviations away from its 1 year mean.

Market Cap | $388.83M |
---|---|

Next Earnings Date | 10/31/2022 (39d) |

Implied Volatility (IV) 30d | 233.68 |

Implied Volatility Rank (IVR) 1y | 31.02 |

Implied Volatility Percentile (IVP) 1y | 76.92 |

Historical Volatility (HV) 30d | 60.76 |

IV / HV | 3.85 |

Open Interest | 4.20K |

Option Volume | 503.00 |

Data was calculated after the 9/21/2022 closing.

- Concrete option trades for the upcoming day
- Portfolios with backtested profitable option strategies
- It's free. Contains just value. Unsubscribe any time.